共 735 条
[1]
Babjuk M(2022)European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ) Eur Urol 81 75-94
[2]
Burger M(2023)Prognosis of primary papillary Ta grade 3 bladder cancer in the non-muscle-invasive spectrum Eur Urol Oncol 6 214-221
[3]
Capoun O(2017)Bladder cancer: diagnosis and management of bladder cancer BJU Int 120 755-765
[4]
Cohen D(2014)The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review Eur Urol 66 1065-1077
[5]
Comperat EM(2014)Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings Clin Nucl Med 39 e308-312
[6]
Dominguez Escrig JL(2013)Epidemiology and risk factors of urothelial bladder cancer Eur Urol 63 234-241
[7]
Gontero P(2020)Complications and quality of life of ileal conduit, orthotopic neobladder and ureterocutaneostomy: systematic review of reports using the Clavien-Dindo classification Minerva Urol Nefrol 72 408-419
[8]
Liedberg F(2021)Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy Urol Oncol 39 835.e8179-835.e839
[9]
Masson-Lecomte A(2023)Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy BJU Int 28 196-208
[10]
Mostafid AH(2021)The genitourinary pathology society update on classification of variant histologies, T1 substaging, molecular taxonomy, and immunotherapy and PD-L1 testing implications of urothelial cancers Adv Anat Pathol 115 455-461